NasdaqCM - Nasdaq Real Time Price USD
Xenetic Biosciences, Inc. (XBIO)
3.1488
-0.0412
(-1.29%)
At close: May 8 at 4:00:00 PM EDT
Major Holders
| Breakdown | |
|---|---|
| 19.05% | % of Shares Held by All Insider |
| 6.65% | % of Shares Held by Institutions |
| 8.22% | % of Float Held by Institutions |
| 14 | Number of Institutions Holding Shares |
Top Institutional Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| Renaissance Technologies, LLC | 25.55k | Dec 31, 2024 | 1.66% | 80,451 |
| Susquehanna International Group, LLP | 15.86k | Dec 31, 2024 | 1.03% | 49,936 |
| Citadel Advisors Llc | 13.38k | Dec 31, 2024 | 0.87% | 42,130 |
| Geode Capital Management, LLC | 11.89k | Dec 31, 2024 | 0.77% | 37,436 |
| LGT Group Foundation | 11k | Dec 31, 2024 | 0.71% | 34,636 |
| Sachetta, LLC | 10.67k | Mar 31, 2025 | 0.69% | 33,585 |
| JTC Employer Solutions Trusteee Ltd | 2.7k | Mar 31, 2025 | 0.18% | 8,501 |
| UBS Group AG | 1.66k | Dec 31, 2024 | 0.11% | 5,214 |
| Alexis Investment Partners, LLC | 25 | Dec 31, 2024 | 0.00% | 78 |
| Bank of America Corporation | 11 | Dec 31, 2024 | 0.00% | 34 |
Top Mutual Fund Holders
| Holder | Shares | Date Reported | % Out | Value |
|---|---|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 9.8k | Dec 31, 2024 | 0.64% | 30,848 |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 6.88k | Mar 31, 2025 | 0.45% | 21,647 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | 2.07k | Mar 31, 2025 | 0.13% | 6,518 |
| Fidelity Concord Street Trust-Fidelity Series Total Market Index Fund | 1.82k | Mar 31, 2025 | 0.12% | 5,740 |
Related Tickers
VTVT vTv Therapeutics Inc.
20.08
+0.30%
AKTX Akari Therapeutics, Plc
1.3400
-4.29%
DARE Daré Bioscience, Inc.
2.9200
+1.04%
ACHV Achieve Life Sciences, Inc.
2.4300
+2.10%
PXMD PaxMedica, Inc.
0.0001
0.00%
TENX Tenax Therapeutics, Inc.
5.82
+2.83%
VRAX Virax Biolabs Group Limited
1.0600
+2.91%
IMRN Immuron Limited
1.9500
+2.09%
XBIT XBiotech Inc.
2.8500
+2.15%
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%